Park Ha Biological Technology Co
BYAH
4 hedge funds and large institutions have $502K invested in Park Ha Biological Technology Co in 2024 Q4 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
0.31% more ownership
Funds ownership: 0% → 0.31% (+0.31%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$150K |
| 2 |
Jane Street
New York
|
+$130K |
| 3 |
HF
HRT Financial
New York
|
+$110K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$16.2K |
Top Sellers
BYAH Hedge Fund Activity: Q4 2024 in Review
4 of the 7,612 institutional investors tracked by Wall St. Rank reported a position in Park Ha Biological Technology Co (BYAH) for Q4 2024, worth a combined $502K.
Buyers outnumbered sellers: 4 funds opened new BYAH positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $150K.
- 4 institutional investors held Park Ha Biological Technology Co (BYAH) as of Q4 2024, up from 0 in Q3 2024.
- Funds reported $502K of Park Ha Biological Technology Co stock for Q4 2024.
- 4 funds opened new Park Ha Biological Technology Co positions in Q4 2024 and 0 closed out, a net change of +4 holders.
- The largest Park Ha Biological Technology Co buyer in Q4 2024 was Citadel Advisors, an estimated $150K added.
Based on aggregated 13F filings for Q4 2024.